Revisiting Foam Sclerotherapy: Challenging the 7 mm Dogma
Haroun Gajraj, a Self-Employed Phlebologist, posted on LinkedIn.
”An excellent demonstration of the utility of Foam Sclerotherapy for Superficial Venous Disease.
Dogma (aka Guidelines) tells us that Foam is only useful for veins up to 7 mm.
Even then, long-term durability is widely thought to be inferior to endothermal ablation.
Thank you Massimo Pozza for sharing your expertise.
Those who get inferior results are not doing it right. Simple as that!”
Quoting Massimo Pozza‘s post:
” This is a very interesting case because the patient had a VGS dilation of about 2.4 cm at 30 cm from the crosse (average diameter calculated on the teaching of Dr. Sica of Paris) with this abnormal antero-medial collateral.
I treated the VGS with direct puncture to the middle lower III of the thigh with 1% R L/A 1/4 foam about 8cc and then I treated the coarse collateral with atxscl 0.5/0.7% foam at the control after about 6 years the patient does not have recanalization of either the VGS or the coarse collateral and I limited myself to the treatment of some small collateral legs.
This is to highlight the
The fact is that very often it is enough to use delicate concentrations to have excellent results and that I prefer to use more aggressive concentrations depending on the patient’s response, which is different from person to person.
I always use Nadiax 3 nanoemulsion cream before and after the treatment and in this case elastocontension 35 mmHg for 7 days.”
” 
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch